PATHOPHYSIOLOGY OF RENAL-FAILURE IN RENOVASCULAR DISEASE

被引:45
作者
TEXTOR, SC
机构
[1] Division of Hypertension and Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota
关键词
RENAL ARTERY STENOSIS; ATHEROSCLEROSIS; ISCHEMIA; NEPHROPATHY; KIDNEY; END-STAGE RENAL DISEASE;
D O I
10.1016/S0272-6386(12)80226-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Recent attention has focused on renovascular compromise as a cause of chronic renal failure. The sequence by which kidneys functioning near the limits of ''critical perfusion pressures'' develop parenchymal injury is not well understood. We studied poststenotic renal pressures, glomerular volume, and renal function in conscious rats using an aortic coarct model during antihypertensive therapy with sodium restriction and angiotensin-converting enzyme inhibition over 4 weeks. These were compared with acute reduction of renal pressures using aortic ligation. Both models reduced poststenotic pressures to 50 to 60 mm Hg. Total aortic ligation produced tubular necrosis and glomerular collapse with 40-fold elevated urinary N-acetyl-glucosaminidase excretion. In contrast, angiotensin-converting enzyme inhibition reduced renal blood flow by 30% without evident disruption in tubular function, reflected by low fractional excretion of sodium levels and normal excretion of N-acetyt-glucosaminidase. The glomerular filtration rate and filtration fraction were reduced. These results indicate that gradual reduction of renal perfusion pressure produces functional and morphologic consequences different from those observed with acute ischemic injury. Mechanisms by which chronic renal perfusion deficits produce tissue injury are reviewed and may include disruption of vascular regulation, energy storage molecules, cellular ion gradients, free radical generation, and disruption of cytoskeletal configuration and repair mechanisms. Further study of the pathways of chronic renal parenchymal injury beyond arterial stenosis is essential to achieve rational intervention and revascularization in humans. (C) 1994 by the National Kidney Foundation, Inc.
引用
收藏
页码:642 / 651
页数:10
相关论文
共 37 条
[1]  
BANTLE JP, 1990, J LAB CLIN MED, V115, P233
[2]  
Burke TJ, 1993, DISEASES KIDNEY, P1257
[3]   ANGIOTENSIN-II INDUCES SMOOTH-MUSCLE CELL-PROLIFERATION IN THE NORMAL AND INJURED RAT ARTERIAL-WALL [J].
DAEMEN, MJAP ;
LOMBARDI, DM ;
BOSMAN, FT ;
SCHWARTZ, SM .
CIRCULATION RESEARCH, 1991, 68 (02) :450-456
[4]   RENOVASCULAR HYPERTENSION IMPAIRS FORMATION OF ENDOTHELIUM-DERIVED RELAXING FACTORS AND SENSITIVITY TO ENDOTHELIN-1 IN RESISTANCE ARTERIES [J].
DOHI, Y ;
CRISCIONE, L ;
LUSCHER, TF .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (02) :349-354
[5]  
DZAU VJ, 1981, HYPERTENSION, V3, P63
[6]  
GRONE HJ, 1986, LAB INVEST, V54, P645
[7]  
GUYTON AC, 1991, TXB MED PHYSL, P205
[8]   CONTROL OF GLOMERULAR-FILTRATION RATE BY RENIN-ANGIOTENSIN SYSTEM [J].
HALL, JE ;
GUYTON, AC ;
JACKSON, TE ;
COLEMAN, TG ;
LOHMEIER, TE ;
TRIPPODO, NC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 233 (05) :F366-F372
[9]  
JACKSON B, 1990, J LAB CLIN MED, V115, P21
[10]   ISCHEMIC RENAL-DISEASE - AN OVERLOOKED CLINICAL ENTITY [J].
JACOBSON, HR ;
KURTIN, P ;
HARRINGTON, JT ;
MADAIO, M ;
MADIAS, NE ;
MILLAN, VG ;
KOPELMAN, R .
KIDNEY INTERNATIONAL, 1988, 34 (05) :729-743